Skip to content

Evaluation of an Intervention to Promote Physical Activity in Outpatients With Mental Disorders

Evaluation of an Intervention to Promote Physical Activity in Outpatients With Mental Disorders: Motivational Determinants of Adherence, Effect on Cognitive Determinants of Physical Activity, Physical Activity, Sitting Time and Clinical Symptoms

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02569619
Acronym
GAF
Enrollment
86
Registered
2015-10-07
Start date
2014-04-30
Completion date
2016-03-31
Last updated
2016-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Disorders

Keywords

Physical Activity, Mental Health, Physical Exercise, Mental disorder, Promotion

Brief summary

The purpose of this study is to determine if a manualised intervention to promote physical activity (MoVo-LISA) is effective to help psychiatric outpatients to increase their level of everyday physical activity.

Detailed description

The Intervention program MoVo-LISA is a psychological intervention that should help participants to increase their level of physical activity for a healthy lifestyle.It contains three sessions (2 group,1 one on one) in the course of two weeks. The intervention focuses on planning and barrier management. Participants develop activity ideas, goals and plans that enable them to integrate physical activity in their everyday routine and how to shield their motivation against barriers and difficulties.The intervention has proven to be effective with patients with pain disorders in rehabilitation. This study examines if the intervention if effective for psychiatric outpatients as well. The intervention is compared to an active control group that receives a similar program that is focusing on a healthy diet. Participants are recruited in the outpatient departements of three hospitals in Berlin and Brandenburg (Charité Universitätsmedizin Berlin - Departement of Psychiatry and Psychotherapy; St. Hewdig Hospital Berlin - Departement of Psychiatry; Oberhavel Hospital Brandenburg, Departement of Psychiatry) and at local psychiatrists in Berlin. Individuals are recruited by posters and flyers in the waiting areas areas or by information of their doctor. Patients can contact the researcher and are, after checked for eligibility, invited to an information event, where they get detailed information on the program and the study. After the information event, participants give written informed consent. The intervention takes place in the outpatient departements of the three hospitals. Clinical information about diagnoses, medication and functioning is obtained by their doctors by mail after the patients released them from confidentiality. The study is an explorative approach to test if the program is suited for psychiatric patients. A sample size of 50 participants that complete the program is planned. All data is collected pseudonymised to protect the identity of the patients.

Interventions

BEHAVIORALHealthy Diet Intervention

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Over 18 years of Age * Patients in one of the psychiatric outpatients or at an local psychiatrist in Berlin * Mental illness (ICD-10: F1-F4) * No contraindications for physical activity * Able to understand german language

Exclusion criteria

* Contraindications to physical activity * Acute suicidality

Design outcomes

Primary

MeasureTime frameDescription
Change in physical activity - objectiveFrom baseline (T1) to 3 month after the intervention (T3)Physical activity is objectively measured using accelerometry (ActiGraph GT1M)
Change in physical activity - subjectiveFrom baseline (T1) to 3 month after the intervention (T3)Physical activity is subjectively measured with the International Physical Activity Questionaire (IPAQ)

Secondary

MeasureTime frameDescription
Change in intention for physical activityFrom baseline (T1) to 1 week after the intervention (T2)Intention for physical activity is measured using two likert scaled items
Change in self concordance of the motivation for physical activityFrom baseline (T1) to 1 week after the intervention (T2)Self concordance of the motivation for physical activity is measured using the Sport- und bewegungsbezogene Selbstkonkordanz Skala, which consists of 12 likert scaled items
Change in outcome expectancies for physical activityFrom baseline (T1) to 1 week after the intervention (T2)Outcome expectancies for physical activity are measured using 6 likert scaled items
Change in planning for physical activityFrom baseline (T1) to 1 week after the intervention (T2)Planning for physical activity is measured using 4 likert scaled items
Change in dietary behaviorFrom baseline (T1) to 3 month after the intervention (T3)Dietary behavior is measured using the Food Frequency Questionnaire (FEL)
Change in psychopathological symptomsFrom baseline (T1) to 3 month after the intervention (T3)Psychopathological symptoms are measured by the Symptom Checklist 27 (SCL-27)
Change in health-related quality of lifeFrom baseline (T1) to 3 month after the intervention (T3)Health-related quality of life is measured using the Sort-Form Health Questionnaire 12 (SF-12)
Change in consumption of portions of fruit and vegetable per dayFrom baseline (T1) to 3 month after the intervention (T3)Consumption of fruit and vegetable is measured using two items asking for the number of portions of fruit and vegetable that are consumed on a regular day (a portion is defined as a hand full). Consumption of fruit and vegetable is then added to check if the WHO recommendation of 5 a day is met
Change in barrier planning for physical activityFrom baseline (T1) to 1 week after the intervention (T2)Barrier planning for physical activity is measured using 4 likert scaled items
Change in self-efficacyFrom baseline (T1) to 1 week after the intervention (T2)Self-efficacy is measured using two likert scaled items

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026